Sleep Apnea News and Research

RSS

Sleep apnea may impact health of young diabetics

A new study suggests that young diabetics may be struggling to get a good night's sleep, resulting in worse control of their blood sugar, poorer school performance and misbehavior.

2 Jan 2012

FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.

26 Dec 2011

Truths and myths about pregnancy, obesity

Ironically, despite excessive caloric intake, many obese women are deficient in vitamins vital to a healthy pregnancy. This and other startling statistics abound when obesity and pregnancy collide. Together, they present a unique set of challenges that women and their doctors must tackle in order to achieve the best possible outcome for mom and baby.

22 Dec 2011

Five weight loss tips for the New Year

With the new year right around the corner, many will be thinking about their New Year's resolution. One of the most popular - losing weight - can also be one of the most difficult to keep. But researchers at Temple's Center for Obesity Research and Education (CORE) work year-round to study the treatment and prevention of obesity.

22 Dec 2011

Survey: 40% of police officers have sleep disorders

A survey of police officers indicated that about 40 percent have a sleep disorder, which was associated with an increased risk of adverse health, safety and performance outcomes, according to a study in the December 21 issue of JAMA.

21 Dec 2011

Children with SDB may have better QOL after adenotonsillectomy

Children may have a better quality of life (QOL) and diminished cardiovascular disease risk from the decreased endothelin 1 (ET-1) levels after adenotonsillectomy, according to new research published in the December 2011 issue of Otolaryngology - Head and Neck Surgery.

20 Dec 2011

Rotech Healthcare acquires three home medical entities

Rotech Healthcare Inc., one of the largest providers of home medical equipment and related products and services, announced today its acquisition of three home medical entities.

19 Dec 2011

NYC Council Member celebrates re-launch of Einstein's Gruss MRRC

At a morning ceremony today, New York City Council Member James Vacca, along with administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University, celebrated the re-launch of Einstein's Gruss Magnetic Resonance Research Center.

17 Dec 2011

VIVUS announces results of Qnexa clinical study on cardiometabolic disease

VIVUS, Inc. today announced that results from the SEQUEL study were published in The American Journal of Clinical Nutrition, a peer-reviewed journal with broad, multidisciplinary readership.

9 Dec 2011

Novel interventions promote CPAP use among people with OSA

People with obstructive sleep apnea are more likely to stick to prescribed treatment when a partner or parent is involved with their treatment, according to a team of sleep researchers.

2 Dec 2011

NovaSom introduces MediTrack OSA management platform

NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing and cost-containment solutions, announces the launch of its next generation MediTrack cloud-based CRM application.

1 Dec 2011

Growth hormone replacement increases bone formation in abdominally obese women

In a new study presented today at the annual meeting of the Radiological Society of North America (RSNA), growth hormone replacement for six months was found to increase bone formation in abdominally obese women.

29 Nov 2011

Obese boy’s mother loses custody

An eight year old boy in third grade from Cleveland Heights, Ohio, has been removed from his home after he grew to 218 pounds, weighing nearly as much as four times the usual. The average weight for an eight-year-old boy is 57 pounds - about one quarter of what the Ohio boy weighs.

28 Nov 2011

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice.

28 Nov 2011

HGNS increases airflow during sleep in patients with OSA

Hypoglossal nerve stimulation (HGNS) produced marked dose-related increases in airflow in obstructive sleep apnea (OSA) patients without arousing them from sleep, according to a new study from the Johns Hopkins Sleep Disorders Center.

25 Nov 2011

Einstein, Montefiore experts available to discuss effects of radiation dose and exposure

Experts from Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University are available for interviews on topics ranging from effects of radiation dose and exposure to MRI imaging to detect brain damage in soccer players due to "heading" and cancer post-treatment imaging during the annual Radiological Society of North America Scientific Assembly.

24 Nov 2011

CWRU receives NHLBI grant to study sleep apnea as possible cause of AF

Case Western Reserve University School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart rhythm.

22 Nov 2011

Cyberonics net sales increase 13% to $53.7M for second quarter 2012

Cyberonics, Inc. today announced results for the quarter ended October 28, 2011.

19 Nov 2011

New white paper on potential role of EBTs in treating obesity

The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.

18 Nov 2011

Cortex third quarter net loss increases to $1,175,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.

14 Nov 2011